Fresh analysis reveals that patients who discontinue new slimming jabs like Mounjaro or Wegovy may regain reduced body mass far faster than those who stop traditional diet and exercise regimens.
Published data in a prominent health publication demonstrates that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing such drugs must be aware of the danger of rapid weight regain when the therapy is stopped," warns expert Dr. Susan Jebb.
That rate of regain implies a return to original mass in about 18 months.
Analyzing Therapies
The analysis, which examined 37 of studies involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.
Scientists emphasize that people who lose weight through diet and exercise generally see a slower weight regain—perhaps 100 grams monthly—once they finish.
Explaining the Rapid Rebound
Experts propose the way of the jabs explains the heightened regain.
These medications copy a body's own chemical called GLP-1, which helps regulate appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its own natural GLP-1, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication means hunger is uncontrolled, making overeating a significant risk."
A Chronic Issue?
Health authorities recommend the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Professionals contend that, due to the significant potential of weight regain, the therapy is often ongoing.
This view is reinforced by drug manufacturers, who state that the results "emphasize the persistent nature of obesity," similar to managing conditions like hypertension.
User Testimonies
People who have come off the jabs describe a intense resurgence of hunger.
"I experienced a trigger flipping and you're instantly extremely hungry," described one woman.
This challenge is worsened if patients have not established lasting lifestyle or habit modifications during therapy.
Widespread Adoption
Recent estimates suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is higher among females compared to men.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, clinicians stress that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent cure and lasting health benefits hinges on combined behavioural management.
